21st Century Necromancer

After the ink had dried, Jounouchi Hiromi held the couplet written by Chen Yu at the entrance of their home. With Chen Yu's help, she managed to paste the couplet on both sides of the door.

"Mr. Chen Yu, why do you still have one more strip in your hand?" Seeing Chen Yu holding another strip of red paper with writing on it, Jounouchi Hiromi looked carefully at both sides of the door, noticed they were both affixed, and asked in confusion, "Where is this strip supposed to be pasted?"

Facing Jounouchi Hiromi's puzzled look, Chen Yu motioned for her to step down from the stool. Then he climbed up, indicating that she should steady it. After she did so, he pasted the final red strip at the very top of the door frame.

"This is called the horizontal scroll. In addition to the first and second lines of the couplet, there must also be a horizontal scroll," Chen Yu explained with a smile as he jumped down from the stool. "The function of the couplet is actually quite similar to Japan's Kadomatsu; it's just that the Kadomatsu is for welcoming gods, while the couplet is for warding off evil. Both are traditional customs; they just vary because of different national customs. If you're interested in these things, Hiromi, I remember I have a book dedicated to Chinese folklore that you could read. Furthermore, all the TV programs today are about New Year's customs, so you could also watch the television."

"I want to read it! Give me the book later, Mr. Chen Yu! I'm very interested in these kinds of cultural things!" Jounouchi Hiromi expressed her excitement, having an irrepressible interest in traditional culture.

"Sure, but let's talk about that tonight. This afternoon, you'll join my mom in playing mahjong," Chen Yu readily agreed to Jounouchi Hiromi's request, but he still discussed it with her first. After all, it was the New Year, and it would seem somewhat inappropriate for her to be reading a book by herself.

"No problem! But aren't the rules of Chinese mahjong a bit different from the Japanese versions? What if I don't know how to play?" Jounouchi Hiromi kindly agreed, although she was a bit worried about the rules of Chinese mahjong, as she said, she didn't know them.

"That's simple, you'll know how to play after a few rounds." Chen Yu laughed and gave the standard answer to her concern.

—————————————————————

In the hospital, Zhu Yiting also learned from Director Liu about Chen Yu's treatment suggestions for Wang Jiancheng, and she instantly fell into a dilemma.

As a surgeon who also graduated from a prestigious school, she obviously understood the tremendous strain on the body of performing stomach and liver cancer surgeries within a short timeframe, as well as the postoperative survival rate and quality of life issues that Chen Yu was concerned about—issues that were inescapable.

Yet, as a surgeon, Zhu Yiting was also well aware that hepatic hilum bile duct cancer, as one of the most difficult to treat malignant tumors in the digestive system, spelled a countdown to death once one was diagnosed with it.

Although there are numerous treatment methods for this cancer, from the preferred surgical treatment to chemotherapy, radiotherapy, immunotherapy, biological therapy, and interventional therapy, even traditional Chinese Herbal Medicine treatments in China, of these diverse methods, the only one that could provide a patient with a chance for a cure was surgical removal of the tumor.

And this disease's surgical resection rate has increased from less than 10% in 1985 to 64.1% through the efforts of generations of medical workers. Only through surgical removal could one completely cure this cancer, and surgery's improvement in postoperative quality of life was far superior to various drainage procedures.

Therefore, when she first learned about this cancer at school, the teacher who taught Zhu Yiting had already informed her that an aggressive surgical approach should be adopted for hepatic hilum bile duct cancer, striving for the tumor's removal.

In fact, surgery was indeed the only current method to cure hepatic hilum bile duct cancer—at least until the broad-spectrum anti-cancer drug developed by Chen Yu was officially introduced to the market. Before then, surgery was the sole curative method.

Zhu Yiting, as a surgeon, understood the burden that surgery would place on Wang Jiancheng, but under these circumstances, it was impossible for her to adopt other methods of treatment. Any other way was merely buying time, and once the condition worsened or the tumor spread, not even surgery would be an option.

However, the reply that Director Liu had heard from Professor Zhang, which he shared with Zhu Yiting, presented a new treatment method before her.

Of course, Zhu Yiting was aware of the paper Chen Yu published on broad-spectrum cancer treatment. Although there was little information domestically, with the developed network technology, Zhu Yiting could manage to find Chen Yu's papers if she searched for them.

In Chen Yu's papers, she saw a new approach to cancer treatment, suppressing tumor cell activity with medication. This wasn't exactly a novel concept, yet prior to Chen Yu proposing broad-spectrum cancer treatment, most methods targeted a specific type of cancer and had significant side effects, failing to maintain long-term suppression of tumor activity, especially in controlling the spread of tumor cells.

Usually, such a method was only used when surgery wasn't an option, or the patient refused surgery, aiming to extend their survival time and improve their quality of life. The treatment approach proposed by Chen Yu, however, was a completely new concept and approach with epoch-making significance for cancer treatment.

For Wang Jiancheng, being able to adopt such a method to suppress liver tumor activity, waiting until his body recuperated from the debilitation of stomach tumor surgery to undergo liver tumor surgery, or even just continuing medication without surgery, would all be far better options than going straight to the operating table today and gambling with his life.
Continue reading at My Virtual Library Empire

However, since Chen Yu published his paper in Japan and is conducting research in Japanese hospitals, logically, even if the medication was officially on the market, entering China would require lengthy approval procedures and clinical verification.

Zhu Yiting was clear that even if the state greenlit the introduction of such medication, the completion of the entire process would still be too long for a cancer patient to wait.

Therefore, if it wasn't for Chen Yu, through his alma mater, facilitating cooperation with Tokyo University Medical School Hospital, allowing Wang Jiancheng to receive this medication under the guise of academic research, even if he was able to enlist Xiehe's experts to operate as he said he could, the chance of survival would only be a toss-up, and optimistically, the postoperative survival time was estimated at only five years.

While Chen Yu's approach on the surface seemed to treat Wang Jiancheng as a test subject, in reality, it circumvented numerous obstacles, allowing him access to this medication for treatment.